{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:37:24Z","timestamp":1777513044326,"version":"3.51.4"},"reference-count":66,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007458","name":"Qatar Foundation","doi-asserted-by":"publisher","award":["NPRP-10-0126-170262"],"award-info":[{"award-number":["NPRP-10-0126-170262"]}],"id":[{"id":"10.13039\/100007458","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007458","name":"Qatar Foundation","doi-asserted-by":"publisher","award":["NPRP11S-0121-180351"],"award-info":[{"award-number":["NPRP11S-0121-180351"]}],"id":[{"id":"10.13039\/100007458","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sidra Precision Medicine Program","award":["SDR400123"],"award-info":[{"award-number":["SDR400123"]}]},{"name":"Sidra Precision Medicine Program","award":["SDR100035"],"award-info":[{"award-number":["SDR100035"]}]},{"DOI":"10.13039\/501100005010","name":"AIRC","doi-asserted-by":"publisher","award":["IG 2018-ID 21846"],"award-info":[{"award-number":["IG 2018-ID 21846"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A cancer immune phenotype characterized by an active T-helper 1 (Th1)\/cytotoxic response is associated with responsiveness to immunotherapy and favorable prognosis across different tumors. However, in some cancers, such an intratumoral immune activation does not confer protection from progression or relapse. Defining mechanisms associated with immune evasion is imperative to refine stratification algorithms, to guide treatment decisions and to identify candidates for immune-targeted therapy. Molecular alterations governing mechanisms for immune exclusion are still largely unknown. The availability of large genomic datasets offers an opportunity to ascertain key determinants of differential intratumoral immune response. We follow a network-based protocol to identify transcription regulators (TRs) associated with poor immunologic antitumor activity. We use a consensus of four different pipelines consisting of two state-of-the-art gene regulatory network inference techniques, regularized gradient boosting machines and ARACNE to determine TR regulons, and three separate enrichment techniques, including fast gene set enrichment analysis, gene set variation analysis and virtual inference of protein activity by enriched regulon analysis to identify the most important TRs affecting immunologic antitumor activity. These TRs, referred to as master regulators (MRs), are unique to immune-silent and immune-active tumors, respectively. We validated the MRs coherently associated with the immune-silent phenotype across cancers in The Cancer Genome Atlas and a series of additional datasets in the Prediction of Clinical Outcomes from Genomic Profiles repository. A downstream analysis of MRs specific to the immune-silent phenotype resulted in the identification of several enriched candidate pathways, including NOTCH1, TGF-$\\beta $, Interleukin-1 and TNF-$\\alpha $ signaling pathways. TGFB1I1 emerged as one of the main negative immune modulators preventing the favorable effects of a Th1\/cytotoxic response.<\/jats:p>","DOI":"10.1093\/bib\/bbab168","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T12:10:29Z","timestamp":1618920629000},"source":"Crossref","is-referenced-by-count":14,"title":["Network-based identification of key master regulators associated with an immune-silent cancer phenotype"],"prefix":"10.1093","volume":"22","author":[{"given":"Raghvendra","family":"Mall","sequence":"first","affiliation":[{"name":"Qatar Computing Research Institute, Hamad Bin Khalifa University, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Saad","sequence":"additional","affiliation":[{"name":"Qatar Computing Research Institute, Hamad Bin Khalifa University, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Roelands","sequence":"additional","affiliation":[{"name":"Cancer Research Department, Research Branch, Sidra Medicince, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darawan","family":"Rinchai","sequence":"additional","affiliation":[{"name":"Cancer Research Department, Research Branch, Sidra Medicince, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Kunji","sequence":"additional","affiliation":[{"name":"Qatar Computing Research Institute, Hamad Bin Khalifa University, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossam","family":"Almeer","sequence":"additional","affiliation":[{"name":"Qatar Computing Research Institute, Hamad Bin Khalifa University, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter","family":"Hendrickx","sequence":"additional","affiliation":[{"name":"Cancer Research Department, Research Branch, Sidra Medicince, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"M Marincola","sequence":"additional","affiliation":[{"name":"Refuge Biotechnologies, Menlo Park, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Ceccarelli","sequence":"additional","affiliation":[{"name":"Department of Electrical Engineering and Information Technology (DIETI), University of Naples \u201dFederico II\u201d, Via Claudio 21, 80215 Naples, Italy"},{"name":"Biogem, Istituto di Biologia e Genetica Molecolare, Via Camporeale, Ariano Irpino (AV)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Bedognetti","sequence":"additional","affiliation":[{"name":"Cancer Research Department, Research Branch, Sidra Medicince, Doha, Qatar"},{"name":"Department of Internal Medicine and Medical Specialities, University of Genova, Genova, Italy"},{"name":"College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,5,13]]},"reference":[{"key":"2021110814402058300_ref1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49498-y","article-title":"Netfactor, a framework for identifying transcriptional regulators of gene expression-based biomarkers","volume-title":"Nature Scientific Reports 9","author":"Ahsen"},{"issue":"8","key":"2021110814402058300_ref2","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.3593","article-title":"Functional characterization of somatic mutations in cancer using network-based inference of protein activity","volume":"48","author":"Alvarez","year":"2016","journal-title":"Nat Genet"},{"issue":"8","key":"2021110814402058300_ref3","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.3593","article-title":"Network-based inference of protein activity helps functionalize the genetic landscape of cancer","volume":"48","author":"Alvarez","year":"2016","journal-title":"Nat Genet"},{"issue":"1","key":"2021110814402058300_ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms9971","article-title":"Systematic pan-cancer analysis of tumour purity","volume":"6","author":"Aran","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"2021110814402058300_ref5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene Ontology: tool for the unification of biology","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet"},{"issue":"2","key":"2021110814402058300_ref6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","article-title":"Comprehensive characterization of cancer driver genes and mutations","volume":"173","author":"Bailey","year":"2018","journal-title":"Cell"},{"issue":"3","key":"2021110814402058300_ref7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ccell.2020.08.013","article-title":"A multi-layer molecular fresco of the immune diversity across hematologic malignancies","volume":"38","author":"Bedognetti","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"2021110814402058300_ref8","first-page":"1","article-title":"Toward a comprehensive view of cancer immune responsiveness: a synopsis from the sitc workshop","volume":"7","author":"Bedognetti","year":"2019","journal-title":"J Immunother Cancer"},{"key":"2021110814402058300_ref9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.coi.2016.02.001","article-title":"Disentangling the relationship between tumor genetic programs and immune responsiveness","volume":"39","author":"Bedognetti","year":"2016","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"2021110814402058300_ref10","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2019.07.019","article-title":"Opposing functions of interferon coordinate adaptive and innate immune responses to cancer immune checkpoint blockade","volume":"178","author":"Benci","year":"2019","journal-title":"Cell"},{"issue":"1","key":"2021110814402058300_ref11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B Methodol"},{"issue":"11","key":"2021110814402058300_ref12","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/s41416-018-0309-1","article-title":"The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer","volume":"119","author":"Bertucci","year":"2018","journal-title":"Br J Cancer"},{"issue":"2","key":"2021110814402058300_ref13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","article-title":"A comparison of normalization methods for high density oligonucleotide array data based on variance and bias","volume":"19","author":"Bolstad","year":"2003","journal-title":"Bioinformatics"},{"key":"2021110814402058300_ref14","first-page":"1","article-title":"Oncoprotein-specific molecular interaction maps (sigmaps) for cancer network analyses","author":"Broyde","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"2","key":"2021110814402058300_ref15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc.2016.124","article-title":"The recurrent architecture of tumour initiation, progression and drug sensitivity","volume":"17","author":"Califano","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"6411","key":"2021110814402058300_ref16","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar3593","article-title":"Pan-tumor genomic biomarkers for pd-1 checkpoint blockade\u2013based immunotherapy","volume":"362","author":"Cristescu","year":"2018","journal-title":"Science"},{"issue":"1","key":"2021110814402058300_ref17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41591-018-0263-8","article-title":"The molecular landscape of glioma in patients with neurofibromatosis 1","volume":"25","author":"D\u2019Angelo","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"2021110814402058300_ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-17811-3","article-title":"Selective inhibition of tgf-$\\beta $1 produced by garp-expressing tregs overcomes resistance to pd-1\/pd-l1 blockade in cancer","volume":"11","author":"de Streel","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"2021110814402058300_ref19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ccell.2020.06.002","article-title":"Immunogenomic landscape of hematological malignancies","volume":"38","author":"Dufva","year":"2020","journal-title":"Cancer Cell"},{"key":"2021110814402058300_ref20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejca.2017.01.035","article-title":"Cancer immunotherapy: opportunities and challenges in the rapidly evolving clinical landscape","volume":"81","author":"Emens","year":"2017","journal-title":"Eur J Cancer"},{"key":"2021110814402058300_ref21","doi-asserted-by":"crossref","first-page":"39709","DOI":"10.1038\/srep39709","article-title":"The pan-cancer pathological regulatory landscape","volume":"6","author":"Falco","year":"2016","journal-title":"Sci Rep"},{"issue":"7687","key":"2021110814402058300_ref22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature25171","article-title":"A metabolic function of fgfr3-tacc3 gene fusions in cancer","volume":"553","author":"Frattini","year":"2018","journal-title":"Nature"},{"issue":"1","key":"2021110814402058300_ref23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.immuni.2013.07.008","article-title":"The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures","volume":"39","author":"Galon","year":"2013","journal-title":"Immunity"},{"issue":"3","key":"2021110814402058300_ref24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1158\/0008-5472.CAN-17-1679","article-title":"Transcription factor activities enhance markers of drug sensitivity in cancer","volume":"78","author":"Garcia-Alonso","year":"2018","journal-title":"Cancer Res"},{"issue":"8","key":"2021110814402058300_ref25","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat Med"},{"issue":"1","key":"2021110814402058300_ref26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40425-018-0316-z","article-title":"Development of pd-1 and pd-l1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations","volume":"6","author":"Gong","year":"2018","journal-title":"J Immunother Cancer"},{"issue":"1","key":"2021110814402058300_ref27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinform"},{"issue":"2","key":"2021110814402058300_ref28","first-page":"e1253654","article-title":"Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis","volume":"6","author":"Hendrickx","year":"2017","journal-title":"Onco Targets Ther"},{"issue":"7","key":"2021110814402058300_ref29","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/carcin\/bgx036","article-title":"Developmental SALL2 transcription factor: a new player in cancer","volume":"38","author":"Hermosilla","year":"2017","journal-title":"Carcinogenesis"},{"issue":"10","key":"2021110814402058300_ref30","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/nprot.2016.117","article-title":"Analyzing and interpreting genome data at the network level with consensuspathdb","volume":"11","author":"Herwig","year":"2016","journal-title":"Nat Protoc"},{"issue":"1","key":"2021110814402058300_ref31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using david bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat Protoc"},{"issue":"3","key":"2021110814402058300_ref32","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A landscape of pharmacogenomic interactions in cancer","volume":"166","author":"Francesco Iorio","year":"2016","journal-title":"Cell"},{"issue":"9","key":"2021110814402058300_ref33","doi-asserted-by":"crossref","first-page":"e12776","DOI":"10.1371\/journal.pone.0012776","article-title":"Inferring regulatory networks from expression data using tree-based methods","volume":"5","author":"Irrthum","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"2021110814402058300_ref34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"suppl_1","key":"2021110814402058300_ref35","doi-asserted-by":"crossref","first-page":"D712","DOI":"10.1093\/nar\/gkq1156","article-title":"ConsensusPathDB: toward a more complete picture of cell biology","volume":"39","author":"Kamburov","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2021110814402058300_ref36","doi-asserted-by":"crossref","first-page":"D793","DOI":"10.1093\/nar\/gks1055","article-title":"The ConsensusPathDB interaction database: 2013 update","volume":"41","author":"Kamburov","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"2021110814402058300_ref37","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1093\/bioinformatics\/btw216","article-title":"ARACNe-AP: gene network reverse engineering through adaptive partitioning inference of mutual information","volume":"32","author":"Lachmann","year":"2016","journal-title":"Bioinformatics"},{"key":"2021110814402058300_ref38","first-page":"504","article-title":"Master regulators used as breast cancer metastasis classifier","volume-title":"Biocomputing 2009","author":"Lim","year":"2009"},{"issue":"5","key":"2021110814402058300_ref39","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1172\/JCI69611","article-title":"Melanoma NOS1 expression promotes dysfunctional IFN signaling","volume":"124","author":"Liu","year":"2014","journal-title":"J Clin Invest"},{"issue":"10","key":"2021110814402058300_ref40","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1158\/1078-0432.CCR-18-1942","article-title":"Wnt\/$\\beta $-catenin pathway activation correlates with immune exclusion across human cancers","volume":"25","author":"Luke","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2021110814402058300_ref41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12918-017-0412-6","article-title":"Detection of statistically significant network changes in complex biological networks","volume":"11","author":"Mall","year":"2017","journal-title":"BMC Syst Biol"},{"issue":"7","key":"2021110814402058300_ref42","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1093\/nar\/gky015","article-title":"RGBM: regularized gradient boosting machines for identification of the transcriptional regulators of discrete glioma subtypes","volume":"46","author":"Mall","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"378","key":"2021110814402058300_ref43","doi-asserted-by":"crossref","first-page":"378","DOI":"10.12688\/f1000research.14258.1","article-title":"An unsupervised disease module identification technique in biological networks using novel quality metric based on connectivity, conductance and modularity","volume":"7","author":"Mall","year":"2018","journal-title":"F1000Research"},{"key":"2021110814402058300_ref44","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1145\/3107411.3107418","article-title":"Differential community detection in paired biological networks","volume-title":"Proceedings of the 8th ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics","author":"Mall","year":"2017"},{"issue":"8","key":"2021110814402058300_ref45","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nmeth.2016","article-title":"Wisdom of crowds for robust gene network inference","volume":"9","author":"Marbach","year":"2012","journal-title":"Nat Methods"},{"issue":"9","key":"2021110814402058300_ref46","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/annonc\/mdy244","article-title":"First-in-human study of LY3039478, an oral notch signaling inhibitor in advanced or metastatic cancer","volume":"29","author":"Massard","year":"2018","journal-title":"Ann Oncol"},{"issue":"1","key":"2021110814402058300_ref47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-19177-y","article-title":"Systematic elucidation of neuron-astrocyte interaction in models of amyotrophic lateral sclerosis using multi-modal integrated bioinformatics workflow","volume":"11","author":"Mishra","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"2021110814402058300_ref48","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2020.11.045","article-title":"A modular master regulator landscape controls cancer transcriptional identity","volume":"184","author":"Paull","year":"2021","journal-title":"Cell"},{"issue":"1","key":"2021110814402058300_ref49","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000617","article-title":"Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response","volume":"8","author":"Roelands","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"1","key":"2021110814402058300_ref50","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.1038\/s41598-019-42784-9","article-title":"Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod","volume":"9","author":"Rozenblit","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"2021110814402058300_ref51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-020-02140-x","article-title":"Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma","volume":"21","author":"Sa","year":"2020","journal-title":"Genome Biol"},{"issue":"2","key":"2021110814402058300_ref52","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.immuni.2021.01.011","article-title":"Germline genetic contribution to the immune landscape of cancer","volume":"54","author":"Sayaman","year":"2021","journal-title":"Immunity"},{"key":"2021110814402058300_ref53","article-title":"An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation","author":"Sergushichev","year":"2016"},{"issue":"1","key":"2021110814402058300_ref54","doi-asserted-by":"publisher","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat Appl Genet Mol Biol"},{"issue":"1","key":"2021110814402058300_ref55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2164-13-156","article-title":"The stable traits of melanoma genetics: an alternate approach to target discovery","volume":"13","author":"Spivey","year":"2012","journal-title":"BMC Genomics"},{"issue":"7559","key":"2021110814402058300_ref56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic $\\beta $-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"issue":"43","key":"2021110814402058300_ref57","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"2021110814402058300_ref58","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","article-title":"Genomic and functional approaches to understanding cancer aneuploidy","volume":"33","author":"Taylor","year":"2018","journal-title":"Cancer Cell"},{"issue":"4","key":"2021110814402058300_ref59","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"2021110814402058300_ref60","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40425-018-0355-5","article-title":"Immune oncology, immune responsiveness and the theory of everything","volume":"6","author":"Turan","year":"2018","journal-title":"J Immunother Cancer"},{"key":"2021110814402058300_ref61","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41416-020-01145-4","article-title":"A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival","author":"Turan","year":"2021","journal-title":"Br J Cancer"},{"issue":"19","key":"2021110814402058300_ref62","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1200\/JCO.2013.49.2157","article-title":"Prediction of response to anticancer immunotherapy using gene signatures","volume":"31","author":"Wang","year":"2013","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"6","key":"2021110814402058300_ref63","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.it.2008.03.002","article-title":"The immunologic constant of rejection","volume":"29","author":"Wang","year":"2008","journal-title":"Trends Immunol"},{"issue":"4","key":"2021110814402058300_ref64","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ccell.2021.01.006","article-title":"Proteogenomic and metabolomic characterization of human glioblastoma","volume":"39","author":"Wang","year":"2021","journal-title":"Cancer Cell"},{"issue":"2","key":"2021110814402058300_ref65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-2289-3","article-title":"Oncogene-dependent function of BRG1 in hepatocarcinogenesis","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis"},{"key":"2021110814402058300_ref66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/82_2010_87","article-title":"Tgf SS function in immune suppression","volume-title":"Negative Co-Receptors and Ligands","author":"Yoshimura","year":"2010"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/22\/6\/bbab168\/41087936\/bbab168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/22\/6\/bbab168\/41087936\/bbab168.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T20:55:19Z","timestamp":1724878519000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbab168\/6274817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,13]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11,5]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbab168","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11]]},"published":{"date-parts":[[2021,5,13]]},"article-number":"bbab168"}}